A Pharmacokinetics Study of Intravenous Ascorbic Acid

NCT02534753 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics

Interventions

DRUG: Ascor L 500® (Ascorbic Acid Injection, USP)

Sponsor

McGuff Pharmaceuticals, Inc.